Get started
Author

T. V. Popkova

Observed names: T Popkova, T Y Popkova, T. POPKOVA, T. Popkova, TV Popkova, Tatiana D. Popkova, Tatiana Popkova
ORCID: 0000-0003-0267-217X
Observed ORCIDs: 0000-0003-0267-217X, 0000-0001-5793-4689
OpenAlex ID: A5031078715
Metabolic syndrome in patients with systemic lupus erythematosus
2008 · T Y Popkova, D S Novikova, et al. · Rheumatology Science and Practice · 10
Early predictor of high cardiovascular risk in systemic lupus erythematosus
2025 · M. V. Shalygina, T. V. Popkova, et al. · Rheumatology Science and Practice · 2
PDF
PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
2022 · M Aristova, T Panafidina, et al. · Lupus Science & Medicine · 1
PDF
PO.3.65 The leptin and adiponectin levels in patients with systemic lupus erythematosus and their relationship with cardiovascular risk factors
2022 · L Kondrateva, Y Gorbunova, et al. · Lupus Science & Medicine · 1
PDF
PO.2.48 Incomplete systemic lupus erythematosus: clinical and immunological manifestations
2022 · T Panafidina, T Popkova, et al. · Lupus Science & Medicine · 1
Ab0361 Tocilizumab Versus Tofacitinib in the 12-month Treatment of Biological-naive Patients With Active Rheumatoid Arthritis
2022 · D. Gerasimova, E. Gerasimova, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0209 Clinical and Diagnostic Significance of Intima-media Thickness, Levels of Soluble Cell Adhesion Molecules and Cd40 Ligand in Rheumatoid Arthritis Patients With Low Cardiovascular Risk
2022 · E. Gerasimova, T. Popkova, et al. · Annals of the Rheumatic Diseases · 1
PDF
The enduring nature of the traditional roots of education in China
2026 · Tatiana D. Popkova · Ufa Humanitarian Journal
PO:02:040 The association between antibodies, complement C3/C4 and clinical features in patients with systemic lupus erythematosus: criterial markers
2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine
PDF
PO:02:039 The association between antibodies and clinical features in patients with systemic lupus erythematosus: non-criterial antibodies
2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine
PDF
PO:03:077 Antithyroid antibodies and thyroid dysfunction in women with systemic lupus erythematosus
2026 · Liubov Kondrateva, Tatiana Panafidina, et al. · Lupus Science & Medicine
PDF
PO:02:051 Diabetes mellitus – associated antibodies in women with systemic lupus erythematosus
2026 · Liubov Kondrateva, Tatiana Panafidina, et al. · Lupus Science & Medicine
PDF
PO:02:041 The frequency of different spectrum of antibodies and complement C3/C4 in patients with systemic lupus erythematosus
2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine
PDF
Relationship between pro-inflammatory cytokines and subclinical myocardial dysfunction in patients with rheumatoid arthritis
2025 · I. G. Kirillova, A. S. Potapova, et al. · Modern Rheumatology Journal
PDF
Association of St2, Galectin-3, N-terminal Pro-brain Natriuretic Peptide, Pentraxin With Myocardial Dysfunction Detected by Speckle-tracking Echocardiography in Patients With Rheumatoid Arthritis Prior to Biological Therapy
2022 · I. KIRILLOVA, T. POPKOVA, et al. · CHEST Journal
PDF
Improvement of Myocardial Function and Dynamics the Level of Blood Biomarkers in Patients With Rheumatoid Arthritis on Antirheumatic Therapy
2022 · I. KIRILLOVA, T. POPKOVA, et al. · CHEST Journal
Ab0226 Clinical Significance of Soluble St2 in Patients With Rheumatoid Arthritis Before the Appointment and After 12 Months of Treatment With Biological Drugs (preliminary Data).
2022 · Y. Gorbunova, T. Popkova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0371 Clinical Significance of Galectin-3 in Patients With Rheumatoid Arthritis Before the Appointment and After 12 Months of Treatment With Biological Drugs (preliminary Data).
2022 · Y. Gorbunova, T. Popkova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0508 Risk Factors for Development of Atherosclerosis in Systemic Lupus Erythematosus
2022 · T. Panafidina, T. Popkova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0530 Cardiovascular Risk Status in Systemic Lupus Erythematosus Patients: Which Algorithms Is the Best?
2022 · T. Panafidina, T. Popkova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0320 Association of the Biomarkers Soluble St2, Galectin-3, N-terminal Pro-brain Natriuretic Peptide, Pentraxin With Myocardial Dysfunction Detected by Speckle Tracking Echocardiography in Patients With Rheumatoid Arthritis Prior to Biological Therapy
2022 · I. Kirillova, T. Popkova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0088 Double-stranded Dna Breaks Are a Marker of the Inflammatory Activity of Rheumatoid Arthritis
2022 · A. Avdeeva, Z. Verizhnikova, et al. · Annals of the Rheumatic Diseases
PDF
Ab0032 Characterization of Peripheral Blood B-cell Subset in Untreated Patients With Systemic Lupus Erythematosus and Systemic Sclerosis
2022 · E. Gerasimova, D. Tabakov, et al. · Annals of the Rheumatic Diseases
PDF
Ab0531 Glucocorticoid-associated Morbidity in Sle Using the Glucocorticoid Toxicity Index
2022 · E. Ermolaeva, E. Aseeva, et al. · Annals of the Rheumatic Diseases
PDF
Ab0426 Therapy Without Glucocorticoids in Patients With Systemic Lupus Erythematosus
2022 · A. Mesnyankina, E. Aseeva, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 28
Citation count: 17
H-index: 2
I10-index: 1
Year
Topic
Type